Analyst Ratings for Xylem (XYL)
XYL Rating Summary
XYL Price Target Summary
- Highest: $33.00 (Atlantic Equities)
- Lowest: $24.00 (Goldman Sachs)
- Average: $29.46
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$29.46 (+5.8%)
Avg. $ Target:
$29.46 (+5.8%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/15/2013 | CL King | Downgrade | Neutral (Buy) |
N/A (N/A) |
28.60 | 27.85 | -2.62% | Details |
| 10/18/2012 | Ladenburg Thalmann | Downgrade | Neutral (Buy) |
27.00 (30.00) |
25.08 | 27.85 | 11.04% | Details |
| 10/17/2012 | DA Davidson | New Coverage | Neutral (N/A) |
28.00 (N/A) |
25.37 | 27.85 | 9.78% | Details |
| 10/12/2012 | Brean Capital | New Coverage | Buy (N/A) |
31.00 (N/A) |
24.32 | 27.85 | 14.51% | Details |
| 6/28/2012 | Goldman Sachs | Downgrade | Sell (Neutral) |
24.00 (29.00) |
24.29 | 27.85 | 14.66% | Details |
| 6/21/2012 | Janney Montgomery Scott | Upgrade | Buy (Neutral) |
32.00 (N/A) |
24.72 | 27.85 | 12.66% | Details |
| 5/24/2012 | BB&T Capital | New Coverage | Buy (N/A) |
32.00 (N/A) |
25.79 | 27.85 | 7.99% | Details |
| 5/16/2012 | Atlantic Equities | New Coverage | Overweight (N/A) |
33.00 (N/A) |
25.21 | 27.85 | 10.47% | Details |
| 2/17/2012 | Citi | New Coverage | Neutral (N/A) |
30.00 (N/A) |
27.15 | 27.85 | 2.58% | Details |
| 12/27/2011 | Gabelli | New Coverage | Buy (N/A) |
N/A (N/A) |
24.91 | 27.85 | 11.8% | Details |
| 12/21/2011 | Canaccord Genuity » Updated 8/3/2012 |
New Coverage | Buy (N/A) |
29.00 (30.00) |
24.31 | 27.85 | 14.56% | Details |
| 12/2/2011 | KeyBanc | New Coverage | Buy (N/A) |
28.00 (N/A) |
24.27 | 27.85 | 14.75% | Details |
| 11/15/2011 | Barclays » Updated 11/23/2011 |
New Coverage | Equalweight (N/A) |
28.00 (N/A) |
23.93 | 27.85 | 16.38% | Details |
| 11/8/2011 | Wedbush » Updated 12/13/2011 |
New Coverage | Outperform (N/A) |
32.00 (N/A) |
24.60 | 27.85 | 13.21% | Details |
| 11/1/2011 | Baird | New Coverage | Neutral (N/A) |
29.00 (N/A) |
26.74 | 27.85 | 4.15% | Details |
